Oxford BioDynamics director sells over 700,000 shares : vima

Oxford BioDynamics PLC - biotechnology company developing precision medicine tests based on the EpiSwitch 3D genomics platform - Reports that Vulpes Testudo Fund, controlled by Non-Executive Director...

Related Keywords

Stephen Diggle , Emma Curzon , Alliance News Ltd , Oxford Biodynamics , Vulpes Life Sciences Funds , Vulpes Testudo Fund , Alliance News , Non Executive Director Stephen Diggle , Vulpes Testudo , Vulpes Life Sciences , All Rights , Markets ,